Why Everything Stops Working in Perimenopause

The metabolic shift explained, and what is actually driving it

At some point in your mid-to-late forties, or sometimes earlier, the strategies that used to work stop working. You eat the way you always ate. You move the way you always moved. And the body you are in seems to be operating under different rules.

It is. And the reason is not mysterious, even if no one has explained it to you clearly.

What is actually changing, and why it is not one thing

Perimenopause is not a single hormonal event. It is a phase of variable, often erratic hormonal fluctuation, primarily involving estrogen but interacting with progesterone, testosterone, cortisol, thyroid hormones, and insulin sensitivity.

Three metabolic changes tend to become visible in this phase: shifting insulin sensitivity, changes in fat distribution toward visceral and abdominal fat, and accelerating muscle loss. These three have overlapping contributing factors, but they do not always move together or at the same pace. Treating them as a single mechanism gives a cleaner story than the biology supports.

The more accurate picture, and the more useful one, is multiple overlapping systems, each with their own entry points. That also means multiple places to intervene.

Why I understand this from the inside

I remember sitting in my gynaecologist's office in tears, not knowing how to explain what was wrong. I was going through a divorce, alone in Hong Kong, and everything felt exponentially harder than it should have. I thought it was the circumstances. It was also my biology. The two were happening at the same time, and I did not yet have the framework to separate them.

That is what this phase can do. It does not just change your body. It changes your capacity to absorb everything else life is asking of you.

Understanding the mechanism did not undo that period. But it explained it. And explanation, it turns out, is its own kind of relief.

Estrogen’s metabolic role

Estrogen receptors are distributed throughout the body: liver, fat cells, muscle, brain, gut lining. Estrogen is not primarily a reproductive hormone. It is a metabolic regulator, and its decline and fluctuation in perimenopause have downstream effects across all of these sites.

On insulin sensitivity: estrogen supports insulin receptor responsiveness. As it declines and fluctuates, glucose disposal becomes less efficient. Cortisol elevation, thyroid function, gut microbiome changes, and physical activity level all contribute here as well. Estrogen is one input, not the only one.

On fat distribution: visceral fat accumulation in perimenopause is associated with declining estrogen combined with rising cortisol, adipose gene expression changes partly mediated by the gut microbiome shift, and reduced muscle mass as a glucose sink. Visceral fat is also metabolically active. It produces inflammatory cytokines, including those that activate the NF-kB inflammatory pathway, which further reduces insulin sensitivity. This is a real cycle, with multiple entry points.

On muscle: estrogen plays a direct role in myosin filament integrity and satellite cell function. As it declines, muscle repair and synthesis capacity are affected. This compounds the insulin sensitivity picture because muscle is the primary site of contraction-mediated glucose disposal.

Each of these processes is real and well-supported. The risk is in presenting them as tightly synchronized when in practice they unfold at different rates and with different weightings depending on the individual.

The variable most perimenopause content ignores: thyroid

The HPT axis regulates thyroid hormone production and conversion. It is the third major feedback loop in the neuroendocrine system, alongside the HPA and HPG axes. Thyroid hormones drive metabolic rate, energy production, temperature regulation, and mood.

Subclinical hypothyroidism, or even suboptimal thyroid function within standard lab ranges, produces symptoms that are almost indistinguishable from perimenopause: fatigue, weight changes, brain fog, mood shifts, disrupted sleep. The two phases frequently co-occur, and women in perimenopause are at increased risk of thyroid autoimmunity, particularly Hashimoto’s thyroiditis.

Magnesium, selenium, zinc, iodine, and adequate protein are all nutrient cofactors for thyroid hormone production and T4-to-T3 conversion. When these are depleted, thyroid function suffers, and the metabolic picture becomes more difficult to read. A TSH alone is not sufficient to assess this; a full panel including free T3, free T4, and antibody markers gives a more complete picture.

If your perimenopause care has not looked at thyroid function in detail, that is a gap worth closing.

Why a single-lever approach rarely resolves this

Because multiple systems are involved, addressing only one tends not to move the whole picture.

Eating less does not fix insulin resistance if cortisol is elevated and thyroid function is suboptimal. Adding cardio does not rebuild muscle if the resistance training stimulus is insufficient. Hormone therapy addresses the estrogen axis meaningfully, and for many women it is the right clinical decision, but it does not on its own address cortisol dysregulation, thyroid function, gut health, or muscle protein synthesis.

These are complementary layers. The research supports an integrated approach: plant-predominant nutrition to support estrobolome health, gut diversity, and anti-inflammatory signaling; progressive resistance training to activate GLUT4 and maintain lean mass; nervous system regulation to support the HPA axis; and where appropriate, hormone therapy to address the estrogen and progesterone picture directly.

Not because the approach is elegant. Because it reflects how the body actually works.

If you want to understand which of these layers matters most for where you are right now, the Perimenopause Metabolic Audit gives you a personalized map. Sixty minutes, a PDF protocol you keep, and a starting point that is specific to you. Book your session here.